[144] Textron, Inc. SEC Filing

Rhea-AI Filing Summary

Textron Inc. (TXT) filed a Form 144 indicating a proposed insider sale. The unidentified filer plans to dispose of 28,543 common shares through Fidelity Brokerage on the NYSE around 25 Jul 2025. At the filing date the shares carried an aggregate market value of $2.27 million, implying an average price near $79.40. The planned sale represents roughly 0.016 % of Textron’s 178.2 million shares outstanding, suggesting limited dilution or market impact.

The shares derive from two employee stock-option grants (3 Mar 2017 and 3 Mar 2020) that were exercised for cash on the same day as the intended sale. No prior sales were reported in the past three months. The signer certifies no possession of undisclosed material adverse information.

Key take-aways for investors:

• Modest insider sale from option exercises; proceeds likely for personal liquidity.
• No indication of broader strategic change or operational weakness.
• Because the transaction is small relative to float, price pressure should be minimal, but insider sentiment warrants monitoring if additional sales follow.

Insights

Securities Analyst

TL;DR: Small Form 144 sale; negligible float impact; watch for follow-on transactions.

The 28.5 k-share planned sale equals ~0.02 days of TXT’s average volume and 0.016 % of outstanding shares—too small to affect valuation on its own. Proceeds stem from in-the-money option exercises, a routine liquidity event. No adverse information is asserted, suggesting ordinary portfolio diversification rather than negative signaling. I classify the filing as immaterial to fundamental outlook; however, serial selling patterns could hint at insider sentiment shifts, so tracking future Forms 4 & 144 remains prudent.

Corporate Governance Expert

TL;DR: Routine option-related sale; governance risk low, disclosure adequate.

The filer followed Regulation 144’s advance-notice rules, listing broker, share count, and acquisition details. Lack of name is permissible if aggregated, but investors lose transparency into individual insider intentions. Still, option-exercise sales after multiyear vesting are standard and do not inherently signal governance concerns. No aggregation with other sales in past three months further reduces red-flag potential. I view the event as neutral for governance risk.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	28543	2265470.29	178205295	07/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/25/2025	Option Granted - 03/01/2017	Issuer			6260	07/25/2025	Cash
Common	07/25/2025	Option Granted - 03/01/2020	Issuer			22283	07/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)